The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Clinical contraindications to allergen immunotherapy: an EAACI position paper
Abstract
Clinical indications for allergen immunotherapy (AIT) in respiratory and Hymenoptera venom allergy are well established; however, clinical contraindications to AIT are not always well documented. There are some discrepancies when classifying clinical contraindications for different forms of AIT as ‘absolute’ or ‘relative’. EAACI Task Force on ‘Contraindications to AIT’ was created to evaluate and review current literature on clinical contraindications, and to update recommendations for both sublingual and subcutaneous AIT for respiratory and venom immunotherapy. An extensive review of the literature was performed on the use of AIT in asthma, autoimmune disorders, malignant neoplasias, cardiovascular diseases, acquired immunodeficiencies and other chronic diseases (including mental disorders), in patients treated with β‐blockers, ACE inhibitors or monoamine oxidase inhibitors, in children under 5 years of age, during pregnancy and in patients with poor compliance. Each topic was addressed by the following three questions: (1) Are there any negative effects of AIT on this concomitant condition/disease? (2) Are more frequent or more severe AIT‐related side‐effects expected? and (3) Is AIT expected to be less efficacious? The evidence, for the evaluation of these clinical conditions as contraindications, was limited, and most of the conclusions were based on case reports. Based on an extended literature research, recommendations for each medical condition assessed are provided. The final decision on the administration of AIT should be based on individual evaluation of any medical condition and a risk/benefit assessment for each patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
Bousquet, J., Mantzouranis, E., Cruz, A. A., Aït-Khaled, N., Baena-Cagnani, C. E., Bleecker, E. R., Brightling, C. E., Burney, P., Bush, A., Busse, W. W., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.07.019 · Cited by 741
Staden, U., Rolinck‐Werninghaus, C., Brewe, F., Wahn, U., Niggemann, B., & Beyer, K. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01501.x · Cited by 466
Casale, T. B., Busse, W. W., Kline, J. N., Ballas, Z. K., Moss, M. H., Townley, R. G., Mokhtarani, M., Seyfert-Margolis, V., Asare, A., Bateman, K., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.036 · Cited by 355
Massanari, M., Nelson, H., Casale, T., Busse, W., Kianifard, F., Geba, G. P., & Zeldin, R. K. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.022 · Cited by 230 · cited 1×
“• The use of premedication, antihistamines or omalizumab (23, 24) as asthma stabilizers in difficult-to-treat patients could broaden the indication of AIT.”
BackgroundSystemic reactions and fatalities associated with allergen immunotherapy
Lockey, R. F., Nicoara-Kasti, G. L., Theodoropoulos, D. S., & Bukantz, S. C. (2001) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62195-3 · Cited by 141
Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab
Schulze, J., Rose, M., & Zielen, S. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01388.x · Cited by 74
Cited by
EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis
Roberts, G., Pfaar, O., Akdis, C. A., Ansotegui, I. J., Durham, S. R., Gerth van Wijk, R., Halken, S., Larenas‐Linnemann, D., Pawankar, R., Pitsios, C., et al. (2018) · Allergy · doi:10.1111/all.13317 · Cited by 702
Self-citationEAACI Guidelines on allergen immunotherapy: IgE‐mediated food allergy
Pajno, G. B., Fernandez‐Rivas, M., Arasi, S., Roberts, G., Akdis, C. A., Alvaro‐Lozano, M., Beyer, K., Bindslev‐Jensen, C., Burks, W., Ebisawa, M., et al. (2018) · Allergy · doi:10.1111/all.13319 · Cited by 566
Self-citationInternational Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
Sturm, G. J., Varga, E. ‐., Roberts, G., Mosbech, H., Bilò, M. B., Akdis, C. A., Antolín‐Amérigo, D., Cichocka‐Jarosz, E., Gawlik, R., Jakob, T., et al. (2018) · Allergy · doi:10.1111/all.13262 · Cited by 479
Self-citation
Metadata
- Authors
- Pitsios, C., Demoly, P., Bilò, M. B., Gerth van Wijk, R., Pfaar, O., Sturm, G. J., Rodriguez del Rio, P., Tsoumani, M., Gawlik, R., Paraskevopoulos, G., Ruëff, F., Valovirta, E., Papadopoulos, N. G., & Calderón, M. A.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2015-05-18
- Volume
- 70
- Issue
- 8
- Pages
- 897-909
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1974435993
- Cited by
- 221
- References
- 7
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical contraindications to allergen immunotherapy: an EAACI position paper. https://app.cochat.ai/papers/10.1111/all.12638
- The paper
- Pitsios, C., Demoly, P., Bilò, M. B., Gerth van Wijk, R., Pfaar, O., Sturm, G. J., Rodriguez del Rio, P., Tsoumani, M., Gawlik, R., Paraskevopoulos, G., Ruëff, F., Valovirta, E., Papadopoulos, N. G., & Calderón, M. A. (2015). Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. https://doi.org/10.1111/all.12638
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.